Alexza Pharmaceuticals

NeuroRX

This company develops small molecule medicines for patients with central nervous system disorders, such as suicidal bipolar depression and post-traumatic stress disorder.

map-pharmaceuticals

This company develops inhaled therapies for neurological and respiratory conditions, such as migraines and asthma, for patients requiring systemic or targeted drug delivery.

Cerevel Therapeutics

This biopharmaceutical company develops neuroscience medicines for patients with mental and neurological conditions including schizophrenia, Parkinson's disease and epilepsy.

Rapport Therapeutics

This company develops small molecule precision medicines for patients suffering from central nervous system disorders.

ProNovo Therapeutics

This biotechnology company develops precision pharmaceutical treatments for patients with neuropsychiatric conditions, such as major depressive disorder and schizophrenia.

Delix

This company develops non-hallucinogenic neuroplasticity-promoting medicines to treat neuropsychiatric and neurodegenerative conditions for patients with brain disorders.

LB Pharmaceuticals

This company develops oral small-molecule antipsychotic therapies for patients with schizophrenia, bipolar depression, and other neuropsychiatric disorders.

Cyclerion Therapeutics

This biopharmaceutical company develops neuropsychiatric therapies for patients with treatment-resistant depression and other neurodegenerative diseases.